Literature DB >> 27601657

Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.

Jonathan R Honegger1, Dana Tedesco2, Jennifer A Kohout3, Mona R Prasad4, Aryn A Price2, Tera Lindquist3, Samantha Ohmer5, Melissa Moore-Clingenpeel6, Arash Grakoui7, Christopher M Walker8.   

Abstract

Chronic hepatitis C virus (HCV) infection is characterized by exhaustion of virus-specific T-cells and stable viremia. Pregnancy is an exception. Viremia gradually climbs during gestation but sometimes declines sharply in the months following delivery. Here, we demonstrated that postpartum HCV control was associated with enhanced virus-specific T-cell immunity. Women with viral load declines of at least 1 log10 between the third trimester and 3-mo postpartum exhibited HCV-specific T-cell responses of greater breadth (P = 0.0052) and magnitude (P = 0.026) at 3-mo postpartum than women who failed to control viremia. Moreover, viral dynamics were consistent in women after consecutive pregnancies, suggesting genetic underpinnings. We therefore searched for genetic associations with human leukocyte antigen (HLA) alleles and IFN-λ3 gene (IFNL3) polymorphisms that influence HCV infection outcome. Postpartum viral control was associated with the IFNL3 rs12979860 genotype CC (P = 0.045 at 6 mo) that predicts a positive response to IFN-based therapy. Suppression of virus replication after pregnancy was also strongly influenced by the HLA class II DPB1 locus. HLA-DPB1 alleles are classified by high and low patterns of expression. Carriage of at least one high-expression HLA-DPB1 allele predicted resurgent virus-specific T-cell immunity and viral control at 3-mo postpartum (P = 0.0002). When considered together in multivariable analysis, IFNL3 and HLA-DPB1 independently affected viral control at 3- and 6-mo postpartum. Together, these findings support a model where spontaneous control of HCV such as sometimes follows pregnancy is governed by genetic polymorphisms that affect type III IFN signaling and virus-specific cellular immune responses.

Entities:  

Keywords:  HLA-DPB1; IFNL3; T-cell; hepatitis C virus; pregnancy

Mesh:

Substances:

Year:  2016        PMID: 27601657      PMCID: PMC5035892          DOI: 10.1073/pnas.1602337113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.

Authors:  Thomas R O'Brien; Ruth M Pfeiffer; Ashley Paquin; Krystle A Lang Kuhs; Sabrina Chen; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Gregory D Kirk; Mark H Kuniholm; Timothy R Morgan; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson
Journal:  J Hepatol       Date:  2015-07-15       Impact factor: 25.083

2.  HCV-RNA levels increase during pregnancy in women with chronic hepatitis C.

Authors:  R Wejstål; A Widell; G Norkrans
Journal:  Scand J Infect Dis       Date:  1998

Review 3.  Adaptive immune responses in acute and chronic hepatitis C virus infection.

Authors:  David G Bowen; Christopher M Walker
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

4.  HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations.

Authors:  Lorenzo Uccellini; Fan-Chen Tseng; Alessandro Monaco; Fatma M Shebl; Ruth Pfeiffer; Myhanh Dotrang; Dianna Buckett; Michael P Busch; Ena Wang; Brian R Edlin; Francesco M Marincola; Thomas R O'Brien
Journal:  Hepatology       Date:  2012-06-01       Impact factor: 17.425

Review 5.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

6.  Global distribution and prevalence of hepatitis C virus genotypes.

Authors:  Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes
Journal:  Hepatology       Date:  2014-07-28       Impact factor: 17.425

7.  Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.

Authors:  Priya Duggal; Chloe L Thio; Genevieve L Wojcik; James J Goedert; Alessandra Mangia; Rachel Latanich; Arthur Y Kim; Georg M Lauer; Raymond T Chung; Marion G Peters; Gregory D Kirk; Shruti H Mehta; Andrea L Cox; Salim I Khakoo; Laurent Alric; Matthew E Cramp; Sharyne M Donfield; Brian R Edlin; Leslie H Tobler; Michael P Busch; Graeme Alexander; Hugo R Rosen; Xiaojiang Gao; Mohamed Abdel-Hamid; Richard Apps; Mary Carrington; David L Thomas
Journal:  Ann Intern Med       Date:  2013-02-19       Impact factor: 25.391

8.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

9.  Variation of transaminases, HCV-RNA levels and Th1/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C.

Authors:  Angeles Ruiz-Extremera; José Antonio Muñoz-Gámez; Ana Abril-Molina; María Angustias Salmerón-Ruiz; Paloma Muñoz-de-Rueda; Esther José Pavón-Castillero; Rosa Quiles-Pérez; Angel Carazo; Ana Gila; Sergio Manuel Jimenez-Ruiz; Jorge Casado; Ana Belén Martín; Laura Sanjuán-Núñez; Esther Ocete-Hita; Julián López Viota; Josefa León; Javier Salmerón
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

10.  Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population.

Authors:  Xiaodong Xu; Ming Yue; Longfeng Jiang; Xiaozhao Deng; Yongxiang Zhang; Yun Zhang; Danyan Zhu; Wen Xiao; Zhenxian Zhou; Wenjuan Yao; Jing Kong; Xiaojie Yu; Juan Wei
Journal:  Int J Mol Sci       Date:  2014-06-03       Impact factor: 5.923

View more
  13 in total

Review 1.  The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Authors:  Effie W Petersdorf; Colm O'hUigin
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

Review 2.  The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.

Authors:  Olusegun O Onabajo; Brian Muchmore; Ludmila Prokunina-Olsson
Journal:  J Interferon Cytokine Res       Date:  2019-06-26       Impact factor: 2.607

Review 3.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

4.  IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.

Authors:  Adeola A Obajemu; Nina Rao; Kari A Dilley; Joselin M Vargas; Faruk Sheikh; Raymond P Donnelly; Reed S Shabman; Eric G Meissner; Ludmila Prokunina-Olsson; Olusegun O Onabajo
Journal:  J Immunol       Date:  2017-10-25       Impact factor: 5.422

5.  CD4+ T cell restoration and control of hepatitis C virus replication after childbirth.

Authors:  Samantha L Coss; Almudena Torres-Cornejo; Mona R Prasad; Melissa Moore-Clingenpeel; Arash Grakoui; Georg M Lauer; Christopher M Walker; Jonathan R Honegger
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

6.  CD4+ T cell responses in human viral infection: lessons from hepatitis C.

Authors:  Benedikt Binder; Robert Thimme
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 7.  Type III Interferons in Hepatitis C Virus Infection.

Authors:  Maude Boisvert; Naglaa H Shoukry
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

8.  Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.

Authors:  Alex S Hartlage; Satyapramod Murthy; Arvind Kumar; Sheetal Trivedi; Piyush Dravid; Himanshu Sharma; Christopher M Walker; Amit Kapoor
Journal:  Nat Commun       Date:  2019-03-07       Impact factor: 14.919

Review 9.  Genetics of the Human Interferon Lambda Region.

Authors:  Ludmila Prokunina-Olsson
Journal:  J Interferon Cytokine Res       Date:  2019-05-08       Impact factor: 2.607

10.  Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.

Authors:  Mohamed Hashem; Ravi Jhaveri; Doa'a A Saleh; Sahar A Sharaf; Fatma El-Mougy; Lobna Abdelsalam; Michelle D Shardell; Hesham El-Ghazaly; Samer S El-Kamary
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.